Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

AGO DESKTOP III/ENGOT-ov20: Impact of secondary cytoreductive surgery in recurrent ovarian cancer

Prof Andreas du Bois - Kliniken Essen Mitte, Essen, Germany
AGO DESKTOP III/ENGOT-ov20: Impact of secondary cytoreductive surgery in recurrent ovarian cancer ( Prof Andreas du Bois - Kliniken Essen Mitte, Essen, Germany )
12 Jun 2020

Three versus six months of adjuvant oxaliplatin and fluoropyrimidine-based therapy for patients with stage III colon cancer

Prof Alberto Sobrero - Ospedale Policlinico San Martino, Genova, Italy
Three versus six months of adjuvant oxaliplatin and fluoropyrimidine-based therapy for patients with stage III colon cancer ( Prof Alberto Sobrero - Ospedale Policlinico San Martino, Genova, Italy )
12 Jun 2020

Checkpoint inhibitors for the treatment of advanced hepatocellular carcinoma

Dr Katie Kelley - University of California San Francisco, San Francisco, USA
Checkpoint inhibitors for the treatment of advanced hepatocellular carcinoma ( Dr Katie Kelley - University of California San Francisco, San Francisco, USA )
12 Jun 2020

COVID-19 and breast cancer: How should we treat our patients?

Dr Javier Cortés - IOB Institute of Oncology, Madrid and Barcelona, Spain
COVID-19 and breast cancer: How should we treat our patients? ( Dr Javier Cortés - IOB Institute of Oncology, Madrid and Barcelona, Spain )
12 Jun 2020

Reducing damage to swallowing muscles during radiotherapy for head and neck cancers

Prof Christopher Nutting - The Royal Marsden NHS Foundation Trust, London, UK
Reducing damage to swallowing muscles during radiotherapy for head and neck cancers ( Prof Christopher Nutting - The Royal Marsden NHS Foundation Trust, London, UK )
12 Jun 2020

Comment: JAVELIN-100 for metastatic urothelial cancer

Dr Elizabeth Plimack - Fox Chase Cancer Center, Philadelphia, USA
Comment: JAVELIN-100 for metastatic urothelial cancer ( Dr Elizabeth Plimack - Fox Chase Cancer Center, Philadelphia, USA )
12 Jun 2020

HCRN GU16-260: Nivolumab and salvage nivolumab ipilimumab in treatment-naïve patients with advanced renal cell carcinoma

Dr Elizabeth Plimack - Fox Chase Cancer Center, Philadelphia, USA
HCRN GU16-260: Nivolumab and salvage nivolumab   ipilimumab in treatment-naïve patients with advanced renal cell carcinoma ( Dr Elizabeth Plimack - Fox Chase Cancer Center, Philadelphia, USA )
12 Jun 2020

Updated results from KEYNOTE-426 for metastatic kidney cancer

Dr Elizabeth Plimack - Fox Chase Cancer Center, Philadelphia, USA
Updated results from KEYNOTE-426 for metastatic kidney cancer ( Dr Elizabeth Plimack - Fox Chase Cancer Center, Philadelphia, USA )
12 Jun 2020

3-weekly cisplatin or weekly cisplatin for squamous cell carcinoma of head and neck

Dr Naomi Kiyota - Kobe University, Kobe, Japan
3-weekly cisplatin or weekly cisplatin for squamous cell carcinoma of head and neck ( Dr Naomi Kiyota - Kobe University, Kobe, Japan )
12 Jun 2020

Osimertinib plus gefitinib for treatment of EGFR-mutated non-small cell lung cancer

Dr Julia Rotow - Dana Farber Cancer Institute, Boston, USA
Osimertinib plus gefitinib for treatment of EGFR-mutated non-small cell lung cancer ( Dr Julia Rotow - Dana Farber Cancer Institute, Boston, USA )
12 Jun 2020

METex14 SAs (MET exon 14 skipping alterations) in non-small cell lung cancer

Prof Mark Awad - Dana Farber Cancer Institute, Boston, USA
METex14 SAs (MET exon 14 skipping alterations) in non-small cell lung cancer ( Prof Mark Awad - Dana Farber Cancer Institute, Boston, USA )
12 Jun 2020

PARP inhibitors in prostate cancer: Choices of tests and how to test?

Dr Kim Chi and Dr Alexander Wyatt
PARP inhibitors in prostate cancer: Choices of tests and how to test? ( Dr Kim Chi and Dr Alexander Wyatt )
11 Jun 2020